About Matthew Bick
Matthew Bick is a chief executive officer and director at Accipiter Biosciences.
Matthew Bick first appears on SEC filings in 2023.
Experience
This experience comes from Matthew Bick's profile and from SEC filings. For roles taken from filings, the years are when the filings name Matthew Bick in the role, so the role may have started earlier or lasted longer.
Accipiter Biosciences Inc. Current
CEO and co-founder (2023 – Present)
Director
2023 – Present · Seattle, WA
Develops computer-designed protein therapies for people with complex diseases.
NT
Neoleukin Therapeutics
Senior Director of Protein Sciences
2020 – 2023
LI
Lyell Immunopharma
Senior Scientist / Project Lead
2019 – 2020
UW
University of Washington
Senior Fellow
2011 – 2018
AB
Avatar Biotechnologies
Independent Consultant
2011
AV
Ascent Biomedical Ventures
Intern
2010 – 2011
TU
The Rockefeller University
Postdoctoral Associate
2000 – 2011
BG
Berhard Nocht Institute for Tropical Medicine, Hamburg German
Research Assistant
2003
UT
University of Cape Town
Summer Undergraduate Research Intern
1999
UR
University of Rochester
Undergraduate Independent Study
1997 – 1999
Key Colleagues at Startups
The people Matthew Bick works with at each company, as listed on that company's latest Form D.
Accipiter Biosciences Inc. · Form D, Jul 28, 2026
RS
Randall Schatzman
Director
Hector De Jesus Rincon Arano
Chief Scientific Officer and director
Javier Castellanos
Chief Technology Officer and director
JC
Jose Antonio Mesa Cejudo
Director
William Canestaro
Chief Strategy Officer/Chief Operations Officer
HR
Heather Redman
Director